12:17 PM EST - AI/ML Innovations Inc : Announced that its minority-owned subsidiary, Tech2Heal SAS, has been selected to participate in the mental health innovation accelerator called IMPACT. Tech2Heal's Mental Health Platform was one of only five projects selected to participate. The winning candidates benefit from a 9-month support program to accelerate their deployment, with significant involvement of IMPACT's founding partners. IMPACT is an innovative public/private partnership formed to develop or accelerate novel solutions to remedy disruptions in the mental health care of adults. AI/ML Innovations Inc
shares C.AIML are trading up 0.01 cent at $0.18.
